Tested TB patients HIV-positive in Upper-middle income (World Bank)
Upper-middle income (World Bank): Tested TB patients HIV-positive was 10.0% in 2024. ▼ Falling
Latest (2024)
10.0%
Change on year
down 9.1%
Rank
6th
of 11 groups
All-time high
32.0%
in 2006
All-time low
10.0%
in 2024
Years of data
22
2003–2024
Tested TB patients HIV-positive in Upper-middle income (World Bank), 2003–2024
Source: World Health Organization, Global Health Observatory.
Analysis
Upper-middle income (World Bank) recorded 10.0% for tested tb patients hiv-positive in 2024. That is the lowest value across all 22 years on record.
Compared with earlier readings it is down 9.1% on the previous year and down 58.3% over ten years.
Over the whole period, tested tb patients hiv-positive in Upper-middle income (World Bank) peaked at 32.0% in 2006 and was at its lowest, 10.0%, in 2024.
The long-run direction has been consistently falling across the 22 years of available data.
Tested TB patients HIV-positive in Upper-middle income (World Bank), year by year
| Year | Value | Change |
|---|---|---|
| 2003 | 22.0% | — |
| 2004 | 27.0% | +22.7% |
| 2005 | 27.0% | +0.0% |
| 2006 | 32.0% | +18.5% |
| 2007 | 28.0% | -12.5% |
| 2008 | 27.0% | -3.6% |
| 2009 | 30.0% | +11.1% |
| 2010 | 27.0% | -10.0% |
| 2011 | 31.0% | +14.8% |
| 2012 | 26.0% | -16.1% |
| 2013 | 25.0% | -3.8% |
| 2014 | 24.0% | -4.0% |
| 2015 | 21.0% | -12.5% |
| 2016 | 20.0% | -4.8% |
| 2017 | 17.0% | -15.0% |
| 2018 | 14.0% | -17.6% |
| 2019 | 12.0% | -14.3% |
| 2020 | 13.0% | +8.3% |
| 2021 | 12.0% | -7.7% |
| 2022 | 13.0% | +8.3% |
| 2023 | 11.0% | -15.4% |
| 2024 | 10.0% | -9.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 27.6% | 22.0% | 32.0% | 7 |
| 2010s | 21.7% | 12.0% | 31.0% | 10 |
| 2020s | 11.8% | 10.0% | 13.0% | 5 |
Countries ranked near Upper-middle income (World Bank)
- 5 South Africa 71.0% compare
- 6 Eswatini 66.0% compare
- 7 Equatorial Guinea 53.0% compare
- 8 Saint Vincent and the Grenadines 50.0% compare
- 9 Lesotho 49.0% compare
- 9 Zimbabwe 49.0% compare
More health data for Upper-middle income (World Bank)
- Pertussis - number of reported cases, gaps filled 63,803 (2025)
- Total tetanus - number of reported cases, gaps filled 5,773 (2025)
- Diphtheria - number of reported cases, gaps filled 1,556 (2025)
- Measles - number of reported cases, gaps filled 91,627 (2025)
- Measles - number of reported cases, annual growth rate -27.52 % change on previous year (2025)
- Pertussis - number of reported cases, annual growth rate -87.69 % change on previous year (2025)
- Total tetanus - number of reported cases, annual growth rate 10.32 % change on previous year (2025)
- Diphtheria - number of reported cases 1,556 (2025)
- Total tetanus - number of reported cases 5,773 (2025)
- Pertussis - number of reported cases 63,803 (2025)
Frequently asked questions
- What is tested tb patients hiv-positive in Upper-middle income (World Bank)?
- Tested tb patients hiv-positive in Upper-middle income (World Bank) was 10.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest tested tb patients hiv-positive recorded in Upper-middle income (World Bank)?
- The highest recorded value was 32.0% in 2006.
- What is the lowest tested tb patients hiv-positive recorded in Upper-middle income (World Bank)?
- The lowest recorded value was 10.0% in 2024.
- How does Upper-middle income (World Bank) rank for tested tb patients hiv-positive?
- Upper-middle income (World Bank) ranks 6th out of 11 groups with data for 2024.
- Is tested tb patients hiv-positive rising or falling in Upper-middle income (World Bank)?
- Over the last ten years it is down 58.3%. The long-run trend across the full record is falling.
- Where does this Upper-middle income (World Bank) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Tested TB patients HIV-positive (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 22 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).